Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Healthcare

Lupin Sets Off Down Indian Pharma's Long Road To Redemption

More than 40 plants have been banned by the FDA for issues ranging from data fraud to hygiene since India's then-largest drugmaker Ranbaxy was pulled up for serious violations in 2008

Read More

Zydus starts second trial of medicine treating anemia

Zydus today (5 July,2017) has announced the initiation of a phase II trial investigating ZYAN1, an oral hypoxia- inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a treatment for anemia associated with chronic kidney disease (CKD).

Read More

'Indian Pharma Sector Growth Likely To Come Down To Single Digit'

In ICRA’s view, continued regulatory interventions in domestic market will put some pressure in near term though long term growth prospects remain healthy given increasing penetration, accessibility and continued new launches by players.

Read More

No Price Change In 78% Of Actively Used Drugs Post GST: NPPA

The National Pharmaceutical Pricing Authority (NPPA) has already announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotics, with a majority being reduced ahead of the GST implementation.

Read More

Wellness: Back To The Roots

Armed with investment in R&D and innovation, India Inc. is now betting big on healing with herbs

Read More

Where Clarity Is A Prime Concern

Some unorganised players in the industry could suffer

Read More

'Women In Rural India Register Gains In Nutrition, Food Security'

Anemia is a leading cause of maternal deaths in India. In India, half of children under three are either stunted or underweight due to malnutrition, and 79 percent are anemic.

Read More

Lupin Founder DB Gupta Passes Away

Indian drug industry losses another doyen after Dr. Parvinder Singh, IA Modi and Ramanbhai Patel

Read More

Fujifilm Aims To Double Revenue From Medical Systems In India

Fujifilm, a leader in the diagnostic imaging space, is also actively engaged in various Public Private Partnership projects floated by government agencies to provide its products and services.

Read More

CSR Boost For Treatment Of Rare Diseases

Rare diseases are those which affect a small percentage of population. They are usually chronic and progressive and because of their complexity, it becomes very difficult to diagnose and treat them.

Read More

'PPP Model In Healthcare Will Help Deliver Efficient Services'

Talking about potential of PPP model in the health sector, NATHEALTH president, Dr Arvind Lal said, "for higher spending in the healthcare sector, PPP projects need to be scaled up and implemented across the country and the government needs to encourage successful projects."

Read More

Saifee Hospital Blames Misled Media For Eman Controversy

The unnecessary controversy will certainly impact India’s reputation as a reliable medical tourism destination among global patient community, say the hospital

Read More

Why Corporate India Should Manage Stress With Yoga?

While talking to BW BusinessWorld Acharya Balkrishna, Managing Director of Patanjali Ayurveda said, “People are managing stocks, money, finance but they forget to manage their own life.”

Read More

Is Running A Yoga Center Profitable In India?

In India, there is a growing awareness among people regarding their health and that is why yoga centers are not just centered in metro cities but also in tier 2 cities.

Read More

Glenmark Acquires Development, Commercial Rights For Novel Cancer Molecule From US Firm

Glenmark Pharmaceuticals entered into a licensing agreement with the Boston-based APC Therapeutics Inc, a biopharmaceutical research firm focused on building a portfolio of immuno-oncology therapies, acquiring rights of a potential cancer drug molecule that is currently under development

Read More